"We're so glad more people with MS will now be able to choose an effective treatment which suits their lifestyle." The list price of Mavenclad is around £2,050 per 10mg tablet, although ...

Germany’s Merck KGaA is facing a big hole in its late-stage pipeline after multiple sclerosis (MS) candidate evobrutinib missed the mark in two phase 3 trials, spelling the end of the programme ...

PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies ...

Liver fibrosis is the build up of scar tissue in the liver when it tries to heal itself. Symptoms may include fatigue, ...

The Symposium will feature scientific leaders who are creating cutting edge technologies and approaches for building the ...

Ritu G. Chopra honored member of the International Association of Top Professionals will be honored at their awards gala in Las Vegas ...

A research team from the University of Minnesota Medical School has identified a strong predictor of ischemic stroke and dementia, a discovery that could lead to improved patient outcomes. The ...

Background Previous natural history studies highlighted a consistent heterogeneity of disability trajectories among ...

Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced the successful conclusion of the eleventh Annual Genedata Partner Symposium (March 31?April 1 ...

Speaking a day before Donald Trump’s reciprocal tariffs are expected to be announced, Karoline Leavitt said: “Our country has ...

PIPELINE HIGHLIGHTS ADG126 - Phase 1b/2 data: 20 mg/kg loading dose followed by 10 mg/kg Q3W in combination with pembrolizumab, Merck’s (known as MSD outside ... development while serving as a ...

Learn more about whether Moderna, Inc. or TG Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.